[Panax notoginseng saponins improve monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting ADAM10/Notch3 signaling pathway]. 2023

Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
Institute of Ischemia/Reperfusion Injury Research, Wenzhou Medical University, Wenzhou 325035, China.

In this study, we investigated the effects of Panax notoginseng saponins (PNS) on pulmonary vascular remodeling and ADAM10/Notch3 pathway in pulmonary arterial hypertension (PAH). PAH rat model was established, and male Sprague Dawley (SD) rats were randomly divided into control group, monocrotaline (MCT) group and MCT+PNS group, with 10 rats in each group. Rats in the control group were intraperitoneally injected with equal volume of normal saline. Rats in the MCT group was injected intraperitoneally with 60 mg/kg MCT on the first day, and then with the same volume of normal saline every day. Rats in the MCT+PNS group was injected intraperitoneally with 60 mg/kg MCT on the first day, and then with 50 mg/kg PNS every day. The modeling time of each group lasted for 21 days. After the model was established, the mean pulmonary artery pressure (mPAP) was measured by right heart catheterization technique, the right ventricular hypertrophy index (RVHI) was calculated, the microscopic morphology and changes of pulmonary vascular wall were observed by HE and Masson staining, and the expressions of ADAM10, Notch3, Hes-1, P27, PCNA, Caspase-3 proteins and mRNA in pulmonary vascular tissue of rats were detected by Western blot and qPCR. The expression and localization of Notch3 and α-SMA were detected by immunofluorescence staining. The protein expression of ADAM10 was detected by immunohistochemical staining. The results showed that compared with the control group, mPAP, RVHI, pulmonary vessels and collagen fibers in the MCT group were significantly increased, the expressions of ADAM10, Notch3, Hes-1, and PCNA protein and mRNA were significantly increased, while the expressions of P27 and Caspase-3 protein and mRNA were decreased significantly. Compared with the MCT group, mPAP and RVHI were significantly decreased, pulmonary vessels were significantly improved and collagen fibers were significantly reduced, the expressions of protein and mRNA of ADAM10, Notch3, Hes-1, and PCNA were decreased in MCT+PNS group, but the expressions of protein and mRNA of P27 and Caspase-3 were increased slightly. The results of immunofluorescence showed that Notch3 and α-SMA staining could overlap, which proved that Notch3 was expressed in smooth muscle cells. The expression of Notch3 in the MCT group was increased significantly compared with that in the control group, while PNS intervention decreased the expression of Notch3. Immunohistochemical staining showed that compared with the control group, the amount of ADAM10 in the MCT group was increased significantly, and the expression of ADAM10 in the MCT+PNS group was decreased compared with the MCT group. These results indicate that PNS can improve the PAH induced by MCT in rats by inhibiting ADAM10/Notch3 signaling pathway.

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D008297 Male Males
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000071656 Receptor, Notch3 A notch receptor characterized by a large extracellular domain containing 34 EPIDERMAL GROWTH FACTOR-like repeats. It functions to regulate CELL DIFFERENTIATION; APOPTOSIS; and CELL PROLIFERATION. Mutations in the EGF repeats of Notch-3 are associated with CADASIL. Neurogenic Locus Notch Homolog Protein 3,Notch-3 Protein,Notch-3 Receptor,Notch3 Protein,Notch3 Receptor,Notch 3 Protein,Notch 3 Receptor
D000077330 Saline Solution A crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY. 0.9% NaCl,0.9% Saline,Normal Saline,Saline, 0.9%,Saline, Normal
D000081029 Pulmonary Arterial Hypertension A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY. Arterial Hypertension, Pulmonary,Hypertension, Pulmonary Arterial
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
January 2015, Experimental lung research,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
February 2018, Pulmonary pharmacology & therapeutics,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
November 2017, Molecular medicine reports,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
January 2014, International journal of clinical and experimental pathology,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
January 2024, Journal of ethnopharmacology,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
October 2016, International journal of cardiology,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
December 2019, Molecular medicine reports,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
July 2010, Journal of natural medicines,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
January 2015, Evidence-based complementary and alternative medicine : eCAM,
Sai Zhang, and Yun-Na Tian, and Zheng-Yang Song, and Xiao-Ting Wang, and Xin-Yu Wang, and Jun-Peng Xu, and Lin-Bo Yuan, and Wan-Tie Wang
May 2018, Molecules (Basel, Switzerland),
Copied contents to your clipboard!